Transition to Recovery
Transition to Recovery
批准号:
10310687
负责人:
SPERO MARTIN MANSON
金额:
$21.01万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-12-15 至 2024-11-30
关键词:
AcuteAddressAdmission activityAftercareAlaskaAlaska NativeAlcohol consumptionAlcoholsAmbulatory CareAmerican IndiansCessation of lifeClinicCommunicationComputerized Medical RecordCost Effectiveness AnalysisCost-Benefit AnalysisDataDrug Metabolic DetoxicationEducationEffectivenessEnrollmentEthnic OriginEvaluationFailureFocus GroupsFosteringGeneral PopulationGoalsHealthHealthcareHealthcare SystemsHomelessnessImpairmentInpatientsInterventionIntoxicationMedicalMental HealthModelingMorbidity - disease rateMothersNative-BornOutcomeParticipantPatientsPatternPeriodicityPersonsPopulationPredictive FactorProcessProviderRaceRandomizedRandomized Controlled TrialsRecoveryResearchResearch Project GrantsResourcesRoleScreening for cancerSeveritiesSocial supportSourceSubstance abuse problemSymptomsTestingTimeTrainingTransportationVulnerable PopulationsWithdrawalWorkaddictionalcohol abuse therapyalcohol researchalcohol riskalcohol use disordercare coordinationcostcost effectivecost estimateeconomic evaluationeconomic valueeffective interventionexperiencehealth administrationhealth disparity populationshigh riskhospital readmissionimprovedmeetingsmortalitymotivational enhancement therapyoutpatient programspatient orientedpatient populationpost interventionpreventprimary outcomeprogramsrandomized trialreadmission ratesrural patientssocialtreatment program
中文摘要
研究项目3摘要
酒精解毒的主要目标是医学管理急性中毒和戒断。其
第二个目标是促进戒毒后进入长期酒精治疗,但这一目标往往被忽视。
这导致了一个旋转门,其特征是出院和再入院的周期性模式,
解毒这种模式在美国酒精戒毒患者中观察到,
在费尔班克斯的阿拉斯加原住民中很普遍,只有2%的人在接受酒精治疗后过渡到酒精治疗。
戒毒,约40%在1年内重新入院。旋转门对病人来说是昂贵的,
提供商目前尚无与解毒费用有关的估计数。一项长达25年的研究
显示平均住院戒毒费用超过3,300元。虽然药物滥用和
精神卫生管理局认识到,需要更好的联系,使人们过渡到治疗
戒毒后,很少有干预措施测试了改善这种过渡的方法;这些先前的干预措施都没有。
研究对象包括阿拉斯加原住民或美洲印第安人。与费尔班克斯原住民合作
协会的网关恢复(GTR),我们建议使用患者导航,以指导和帮助患者,
过渡到适当的治疗水平,并帮助消除阻碍进入治疗的障碍。我们
研究首先使用GTR的电子病历数据来确定预测治疗过渡的因素,
在过去5年中观察到的约1,000名患者中再次入院戒毒。第二,我们将利用这一点
信息与由关键利益相关者组成的焦点小组相结合,以确定适当的导航员角色
和酒精解毒患者的方法。然后,我们将进行一项随机对照试验,
700例患者的改良干预。第三,我们将估计实施和维持这一目标的成本。
干预,过渡到复苏,以及其经济价值。我们的控制条件将包括1个会话
动机访谈,将包括目标设定和战略,以减少酒精消费后,
解毒排出物我们的具体目标是:1)使用约1,000名患者的电子病历数据
确定与戒毒后过渡到酒精治疗和重新入院有关的因素,
2)适应过渡到恢复,以适应GTR患者人群,并测试其有效性,
增加在30天内过渡到戒毒后治疗,并防止在1年内重新入院;以及
3)通过使用成本效益和成本效益对过渡到恢复进行全面的经济评估,
有效性分析。这是第一个使用患者导航器来增强
戒毒后过渡到酒精治疗。如果有效,这种干预可能是一种具有成本效益的方法。
使戒毒患者过渡到全国卫生保健系统治疗的手段。
英文摘要
RESEARCH PROJECT 3 ABSTRACT
The primary goal of alcohol detoxification is to medically manage acute intoxication and withdrawal. Its
secondary goal of fostering entry into longer-term alcohol treatment post-detoxification is often overlooked.
This leads to a revolving door characterized by a cyclical pattern of discharges and readmissions to
detoxification. This pattern is observed across the US among alcohol detoxification patients and is even more
prevalent among Alaska Native people in Fairbanks where only 2% transition to alcohol treatment following
detoxification and approximately 40% are readmitted within 1 year. The revolving door is costly to patients and
providers. Current estimates associated with the cost of detoxification are not available. A study over 25 years
ago indicated the average inpatient detoxification stay was over $3,300. Although the Substance Abuse and
Mental Health Administration recognizes that better linkages are needed to transition people to treatment
following detoxification, few interventions have tested ways to improve this transition; none of these prior
studied included either Alaska Natives or American Indians. In partnership with the Fairbanks Native
Association’s Gateway to Recovery (GTR), we propose to use patient navigators to guide and assist patients in
transitioning to appropriate levels of treatment, and to help eliminate barriers that obstruct treatment entry. Our
study first uses GTR’s electronic medical record data to identify factors that predict transition to treatment and
readmission to detoxification among ~1,000 patients seen over the prior 5 years. Second, we will use this
information, combined with focus groups comprised of key stakeholders, to identify appropriate navigator roles
and processes for alcohol detoxification patients. We will then conduct a randomized controlled trial of the
modified intervention with 700 patients. Third, we will estimate the costs of implementing and sustaining this
intervention, Transition to Recovery, as well as its economic value. Our control condition will include 1 session
of motivational interviewing that will include goal setting and strategies to reduce alcohol consumption after
detoxification discharge. Our Specific Aims are to: 1) Use electronic medical record data from ~1,000 patients
to identify factors associated with post-detoxification transition to alcohol treatment and readmission to
detoxification; 2) Adapt Transition to Recovery to fit the GTR patient population and test its effectiveness in
increasing transition to post-detoxification treatment within 30 days and prevent readmission within 1 year; and
3) Perform a comprehensive economic evaluation of Transition to Recovery by using cost-benefit and cost-
effectiveness analyses. This is the first randomized controlled intervention to use patient navigators to enhance
transition to alcohol treatment following detoxification. If effective, this intervention may be a cost-effective
means of transitioning detoxification patients to treatment across health care systems nationally.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colorado Resource Center for Tribal Epidemiology Centers
-
批准号:10532624
-
项目类别:
-
资助金额:$228.6万
-
财政年份:2022
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Colorado Resource Center for Tribal Epidemiology Centers
-
批准号:10666650
-
项目类别:
-
资助金额:$219.29万
-
财政年份:2022
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Collaborative Hub to Reduce the Burden of Suicide among Urban American Indian and Alaska Native Youth
-
批准号:10186826
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2017
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Collaborative Hub to Reduce the Burden of Suicide among Urban American Indian and Alaska Native Youth
-
批准号:10186827
-
项目类别:
-
资助金额:$82.63万
-
财政年份:2017
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Effectiveness of advanced practice pharmacy services among American Indian and Alaska Native adults with diabetes
-
批准号:9379777
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2017
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Consortium Core
-
批准号:9196918
-
项目类别:
-
资助金额:$54.56万
-
财政年份:2016
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Technology-Based Health Services for American Indian and Alaska Native People
-
批准号:9071421
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2016
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Trauma Screening, brief intervention and referral among AI/AN adults
-
批准号:8859986
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2015
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Technology-Based Health Services for American Indian and Alaska Native People
-
批准号:8859987
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2015
-
负责人:SPERO MARTIN MANSON
-
依托单位:
RESEARCH TRAINING/EDUCATION CORE
-
批准号:8859991
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2015
-
负责人:SPERO MARTIN MANSON
-
依托单位:
CENTER FOR AMERICAN INDIAN AND ALASKA NATIVE DIABETES TRANSLATION RESEARCH
-
批准号:9186861
-
项目类别:
-
资助金额:$62.81万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Trauma Screening, brief intervention and referral among AI/AN adults
-
批准号:8354749
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Technology-Based Health Services for American Indian and Alaska Native People
-
批准号:8354750
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
CENTER FOR AMERICAN INDIAN AND ALASKA NATIVE DIABETES TRANSLATION RESEARCH
-
批准号:9766241
-
项目类别:
-
资助金额:$50.45万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
RESEARCH TRAINING/EDUCATION CORE
-
批准号:8354757
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Administrative Core
-
批准号:8453619
-
项目类别:
-
资助金额:$15.29万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Adminstrative Core
-
批准号:8354753
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2012
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Center for American Indian and Alaska Native Diabetes Translational Research
-
批准号:8546347
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2011
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Administrative Core
-
批准号:10683205
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2011
-
负责人:SPERO MARTIN MANSON
-
依托单位:
Center for American Indian and Alaska Native Diabetes Translational Research
-
批准号:8333957
-
项目类别:
-
资助金额:$36.33万
-
财政年份:2011
-
负责人:SPERO MARTIN MANSON
-
依托单位:
海外基金